Jennifer Galich, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 22032 El Paseo, #130, Rancho Santa Margarita, CA 92688 Phone: 949-546-9588 |
Payal Joshi, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 12 Vista La Cuesta, Rancho Santa Margarita, CA 92688 Phone: 714-827-3000 |
Julie Soria, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 22032 El Paso, #130, Rancho Santa Margarita, CA 92688 Phone: 949-546-9958 |
Katie Da Thao Nguyen, RN, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1 Seacountry Ln, Rancho Santa Margarita, CA 92688 Phone: 949-292-4873 |
Ms. Vivian Nguyen Duong, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 30251 Esperanza # R115, Rancho Santa Margarita, CA 92688 Phone: 949-713-7070 Fax: 949-713-8994 |
Tami Beth Kennedy, NP Nurse Practitioner - Women's Health Medicare: Not Enrolled in Medicare Practice Location: 22411 Antonio Pkwy Ste C120, Rancho Santa Margarita, CA 92688 Phone: 949-709-4141 |
Beeta Rahmani, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 22032 El Paseo Ste 100, Rancho Santa Margarita, CA 92688 Phone: 949-326-9009 |
Tiffany Ellis, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 22032 El Paseo Ste 130, Rancho Santa Margarita, CA 92688 Phone: 949-546-9958 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that it has received $426,000 in grant funding under the Qualifying Therapeutic Discovery Project (QTDP) Program. The program, funded through the US Patient Protection and Affordable Care Act of 2010, supports therapeutic discovery programs.
Researchers have found that the anti-parasite drug benznidazole may improve the long-term prognoses of patients with chronic Chagas disease, according to a study published in PLOS Neglected Tropical Diseases, by Clareci Silva Cardoso at the Federal University of São João del-Rei, Divinópolis, Brazil, and colleagues from the SaMi-Trop study, a project funded by NIAID/NIH.
For the first time, researchers from the Wellcome Trust Sanger Institute and their collaborators have been able to identify in human cancers two characteristic patterns of DNA damage caused by ionising radiation.
Men with low-risk prostate cancer who previously had to choose between aggressive treatment, with the potential for significant side effects, and active surveillance, with the risk of disease progression, may have a new option.
› Verified 2 days ago